Replimune (REPL) Other Accumulated Expenses (2018 - 2021)
Replimune (REPL) reported Other Accumulated Expenses of $514000.0 for Q1 2021, up 69.64% on a YoY basis from $303000.0 in Q1 2020, and down 0.96% sequentially from $519000.0 in Q4 2020.
Replimune (REPL) Other Accumulated Expenses (2018 - 2021) Analysis & Trends
Replimune (REPL) has 4 years of Other Accumulated Expenses data on file, last reported at $514000.0 in Q1 2021.
- For the quarter ending Q1 2021, Other Accumulated Expenses rose 69.64% year-over-year to $514000.0; the trailing twelve-month figure through Mar 2021 stood at $514000.0 (up 69.64% YoY), and the FY2021 full-year result was $514000.0, up 69.64% from the prior year.
- Other Accumulated Expenses slipped to $514000.0 in Q1 2021, from $519000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $974000.0 in Q3 2020 to a low of $129000.0 in Q2 2018.
- A 4-year average of $379538.5 and a median of $303000.0 in 2020 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses advanced 2.33% in 2019 and soared 335.61% in 2020, its largest moves.
- Tracing REPL's Other Accumulated Expenses over 4 years: stood at $251000.0 in 2018, then surged by 37.45% to $345000.0 in 2019, then soared by 50.43% to $519000.0 in 2020, then retreated by 0.96% to $514000.0 in 2021.
- Business Quant data shows REPL's Other Accumulated Expenses at $514000.0 in Q1 2021, $519000.0 in Q4 2020, and $974000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 514,000.00 |
| Dec 31, 2020 | 519,000.00 |
| Sep 30, 2020 | 974,000.00 |
| Jun 30, 2020 | 575,000.00 |
| Mar 31, 2020 | 303,000.00 |
| Dec 31, 2019 | 345,000.00 |
| Sep 30, 2019 | 608,000.00 |
| Jun 30, 2019 | 132,000.00 |
| Mar 31, 2019 | 273,000.00 |
| Dec 31, 2018 | 251,000.00 |
| Sep 30, 2018 | 158,000.00 |
| Jun 30, 2018 | 129,000.00 |
| Mar 31, 2018 | 153,000.00 |